Netherlands
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.34 B
|
Dec. 31, 2023 | USD 662.53 | -0.67% |
|
Netherlands |
|
2 |
USD 362.72 M
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
|
3 |
USD 359.15 M
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
|
4 |
USD 230.09 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
5 |
USD 16.61 M
|
Dec. 31, 2023 | USD 127.21 | -1.46% |
|
Netherlands |
|
6 |
USD 8.91 M
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
7 |
USD -571.00 K
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
8 |
USD -1.04 M
|
Dec. 31, 2023 | USD 8.76 | -0.46% |
|
Netherlands |
|
9 |
USD -2.51 M
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
10 |
USD -433.83 M
|
Dec. 31, 2023 | USD 44.64 | 0.29% |
|
Netherlands |
|
11 |
USD -935.98 M
|
Dec. 31, 2023 | USD 27.61 | 1.08% |
|
Netherlands |
|
12 |
USD -4.17 B
|
Dec. 31, 2023 | USD 36.37 | -0.03% |
|
Netherlands |
The Healthcare company in Netherlands with the highest Net Cash Used Provided By Financing Activities is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD 1.34 B.
The Healthcare company in Netherlands with the lowest Net Cash Used Provided By Financing Activities is Koninklijke Ahold Delhaize N.V. (Amsterdam Stock Exchange: AD.AS) at USD -4.17 B.
The top 10 Healthcare companies in Netherlands by Net Cash Used Provided By Financing Activities are argenx SE, uniQure N.V., Pharvaris N.V., Merus N.V., Redcare Pharmacy NV, NewAmsterdam Pharma Company N.V., LAVA Therapeutics N.V., Pharming Group N.V., ProQR Therapeutics N.V. and Qiagen N.V..
The bottom 10 Healthcare companies in Netherlands by Net Cash Used Provided By Financing Activities are Koninklijke Ahold Delhaize N.V., Koninklijke Philips N.V., Qiagen N.V., ProQR Therapeutics N.V., Pharming Group N.V., LAVA Therapeutics N.V., NewAmsterdam Pharma Company N.V., Redcare Pharmacy NV, Merus N.V. and Pharvaris N.V..